Target intelligence / Profile preview

Transient receptor potential cation channel subfamily V member 1 (TRPV1) and Transient receptor potential cation channel subfamily A member 1 (TRPA1) (TRPV1/TRPA1)

Target
TRPV1/TRPA1
Molecular classification
Ion channel, Transient receptor potential (TRP) channel family, Receptor
01

Overview

The TRPV1 and TRPA1 channels are non-selective cation channels belonging to the Transient Receptor Potential (TRP) superfamily, primarily expressed in nociceptive sensory neurons [1.4.1]. TRPV1, known as the capsaicin receptor, is activated by noxious heat (>43°C), low pH, and vanilloids, while TRPA1, the wasabi receptor, responds to noxious cold (<17°C) and various electrophilic irritants [1.3.1, 1.4.5]. These channels are frequently co-expressed and functionally interlinked, playing a critical role in the integration of painful stimuli and the mediation of neurogenic inflammation through the release of neuropeptides like CGRP and substance P [1.4.1, 1.4.4]. In disease states, they contribute to chronic pain, respiratory conditions like asthma and cough, and inflammatory skin disorders [1.2.1, 1.4.3]. Therapeutic strategies involve the development of dual antagonists to provide enhanced analgesic and anti-inflammatory effects compared to single-target agents [1.1.1, 1.2.2]. However, clinical development has faced significant challenges, such as TRPV1-mediated hyperthermia and the risk of impaired thermal sensation, which can lead to scalding injuries [1.1.1, 1.3.1].

Other names
Capsaicin receptorVanilloid receptor 1VR1Wasabi receptorAnkyrin-like protein with transmembrane domainsANKTM1OTRPC1
02

Mechanism of action

Antagonism of the ion channels to inhibit cation influx and subsequent neuronal depolarization, or desensitization through prolonged agonism [1.1.1, 1.4.3].

03

Biological functions

Signal transductionNociceptionThermosensationNeurogenic inflammationImmune responseCough reflexMicturition reflex
04

Disease associations

InflammationChronic painNeuropathic painOsteoarthritisMigraineAsthmaCOPDAtopic dermatitisPruritusInflammatory bowel disease
05

Safety considerations

HyperthermiaImpaired noxious heat sensationRisk of scalding injuriesPharmacokinetic challenges [1.1.1, 1.3.1]
06

Interacting drugs

Capsaicin

12 more in the full profile.

07

Biomarkers

Capsaicin-induced dermal blood flowHeat pain thresholdCold pain thresholdPlasma calcitonin gene-related peptide (CGRP) levelsSubstance P levels

Beyond the preview

Go deeper on Transient receptor potential cation channel subfamily V member 1 (TRPV1) and Transient receptor potential cation channel subfamily A member 1 (TRPA1) (TRPV1/TRPA1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transient receptor potential cation channel subfamily V member 1 (TRPV1) and Transient receptor potential cation channel subfamily A member 1 (TRPA1) (TRPV1/TRPA1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call